| First-in-class Biologic Agent for Kidney Transplant Rejection Approved in Europe - SYS-CON Media (press release) |
|
|
SYS-CON Media (press release) By acting selectively on the immune system to prevent graft rejection, belatacept helps safeguard renal function, which is increasingly recognized as a key predictor of long term outcomes in kidney transplant recipients, impacting both patient and |